- Report
- October 2024
- 197 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- November 2024
- 100 Pages
Global
From €5408EUR$5,950USD£4,592GBP
- Report
- April 2025
- 66 Pages
Global
From €5317EUR$5,850USD£4,515GBP
- Report
- April 2025
- 191 Pages
Global
From €5317EUR$5,850USD£4,515GBP
- Report
- April 2025
- 175 Pages
Global
From €4081EUR$4,490USD£3,466GBP
- Report
- February 2025
- 200 Pages
Global
From €4081EUR$4,490USD£3,466GBP
- Report
- November 2024
- 150 Pages
Global
From €4408EUR$4,850USD£3,743GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1136EUR$1,250USD£965GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1136EUR$1,250USD£965GBP
- Report
- April 2025
Global
From €4454EUR$4,900USD£3,782GBP
- Report
- March 2025
- 190 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- October 2024
- 198 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- October 2024
- 182 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- October 2024
- 183 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- October 2024
- 180 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- July 2024
- 120 Pages
Global
From €5408EUR$5,950USD£4,592GBP
- Report
- April 2025
- 181 Pages
Global
From €5317EUR$5,850USD£4,515GBP
- Report
- April 2025
- 276 Pages
Global
From €5317EUR$5,850USD£4,515GBP
- Report
- April 2025
- 413 Pages
Global
From €5317EUR$5,850USD£4,515GBP
- Report
- April 2025
- 150 Pages
Global
From €5317EUR$5,850USD£4,515GBP

The Anti Tumour Necrosis Factor (anti-TNF) market is a subset of the Immune Disorders Drugs market. Anti-TNF drugs are used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by blocking the action of TNF, a protein that is involved in inflammation and tissue destruction. Anti-TNF drugs are generally administered as injections or infusions, and are often used in combination with other medications.
The anti-TNF market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, Janssen, Merck, Pfizer, and UCB. Each company has its own portfolio of anti-TNF drugs, and they are continually developing new products to meet the needs of patients. Show Less Read more